Cnb Bank Bristol Myers Squibb CO Transaction History

Cnb Bank

$207 Million
Q2 2024

A detailed history of Cnb Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cnb Bank holds 7,749 shares of BMY stock, worth $419,840. This represents 0.16% of its overall portfolio holdings.

Number of Shares

7,749

Previous 8,571 9.59%

Holding current value

$419,840

Previous $464,000 30.82%

% of portfolio

0.16%

Previous 0.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $33,085 - $43,557	-822 Reduced 9.59%	7,749 $321,000
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $20,631 - $23,392	-430 Reduced 4.78%	8,571 $464,000
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $5,090 - $6,074	-105 Reduced 1.15%	9,001 $461,000
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $18,351 - $20,519	317 Added 3.61%	9,106 $528,000
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $31,154 - $34,591	489 Added 5.89%	8,789 $562,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $9,856 - $11,179	-150 Reduced 1.78%	8,300 $575,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $10,956 - $12,974	-160 Reduced 1.86%	8,450 $607,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $56 - $33,348	-434 Reduced 4.8%	8,610 $612,000
Q2 2022 Aug 19, 2022	SELL	$72.62 - $79.98 $427,150 - $470,442	-5,882 Reduced 39.41%	9,044 $696,000
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $396,868 - $437,090	5,465 Added 57.76%	14,926 $1.15 Million
Q1 2022 Apr 13, 2022	SELL	$61.48 - $73.72 $29,203 - $35,017	-475 Reduced 4.78%	9,461 $691,000
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $9,814 - $11,441	-183 Reduced 1.81%	9,936 $620,000
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $24,023 - $28,139	-406 Reduced 3.86%	10,119 $599,000
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $10,524 - $11,461	170 Added 1.64%	10,525 $703,000
Q1 2021 May 03, 2021	SELL	$59.34 - $66.74 $3,560 - $4,004	-60 Reduced 0.58%	10,355 $654,000
Q4 2020 Jan 27, 2021	SELL	$57.74 - $65.43 $23,557 - $26,695	-408 Reduced 3.77%	10,415 $646,000
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $174,070 - $192,892	-3,031 Reduced 21.88%	10,823 $653,000
Q2 2020 Jul 14, 2020	SELL	$54.82 - $64.09 $49,283 - $57,616	-899 Reduced 6.09%	13,854 $815,000
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $94,795 - $137,759	-2,043 Reduced 12.16%	14,753 $822,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $75,537 - $98,531	1,535 Added 10.06%	16,796 $1.08 Million
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $97,686 - $115,821	-2,284 Reduced 13.02%	15,261 $774,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $58,630 - $64,832	-1,314 Reduced 6.97%	17,545 $796,000
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $68,447 - $81,614	1,517 Added 8.75%	18,859 $900,000
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $35,692 - $46,284	732 Added 4.41%	17,342 $902,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $26,601 - $30,004	-482 Reduced 2.82%	16,610 $1.03 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $6,872 - $8,565	-136 Reduced 0.79%	17,092 $946,000
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $103,541 - $119,197	1,728 Added 11.15%	17,228 $1.09 Million
Q4 2017 Feb 20, 2018	BUY	$59.94 - $65.35 $929,070 - $1.01 Million	15,500	15,500 $950,000

Others Institutions Holding BMY

# of Institutions

2,404

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Account